Regulation of dopamine D2 receptors by sodium and pH

KA Neve

Medical Research Service, VA Medical Center, Portland, Oregon.

The role of Na+ and H+ in the regulation of D2 receptor affinity for ligands was studied to determine the molecular mechanisms of this phenomenon. The potency of substituted benzamide derivatives and agonists at D2 receptors depended on the concentration of Na+ and H+, whereas the potency of other antagonists was relatively unaltered by changes in pH or Na+ concentration. The potency of agonists was generally decreased in the presence of NaCl or lowered pH. For example, in the absence of sodium the affinity of D2 receptors for dopamine was decreased 17-fold by lowering of the pH from 8.0 to pH 6.8. Addition of NaCl caused 2-4-fold decreases in affinity for most agonists. The affinity of the receptors for two substituted benzamide derivatives, on the other hand, was reduced 6-44-fold by elevated concentrations of H+ but was enhanced 7-24-fold in the presence of Na+. The regulation by H+ of the potency of dopamine was selective for D2 receptors, because binding of dopamine to neostriatal D1 receptors was unaffected by changes in pH. Decreasing of the pH from 8.0 or 7.3 to 6.8 facilitated the dissociation of the substituted benzamide ligand [125I]epidepride from D2 receptors but inhibited dissociation of [3H]spiperone. Furthermore, the presence of NaCl or lowered pH slowed inactivation of D2 receptors by N-ethylmaleimide. Together, these data suggest that the conformation of D2 receptors is regulated by both Na+ and H+. The affinity of D2 receptors for agonists and substituted benzamide antagonists varies according to the conformational state of the receptors, whereas other antagonists bind to both forms with approximately equal potency. Amiloride is a compound that interacts with many sodium-binding macromolecules. At equilibrium, amiloride inhibited the binding of [3H]spiperone and [125I]epidepride in a manner suggesting a more complex interaction than simple competitive inhibition. The rate of dissociation of both radioligands was enhanced by amiloride, as would be expected for allosteric inhibition of binding. The sensitivity of D2 receptors to pH, sodium, and amiloride may be a reflection of the ability of D2 receptors to modulate Na+/H+ exchange.

Volume 39, Issue 4, pp. 570-578, 04/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				G. Swaminath, T. W. Lee, and B. Kobilka Identification of an Allosteric Binding Site for Zn2+ on the beta 2 Adrenergic Receptor J. Biol. Chem., January 3, 2003; 278(1): 352 - 356. [Abstract] [Full Text] [PDF]

				S. Vanni, G. Polidori, I. Cecioni, S. Serni, M. Carini, and P. A. Modesti ETB Receptor in Renal Medulla Is Enhanced by Local Sodium During Low Salt Intake Hypertension, August 1, 2002; 40(2): 179 - 185. [Abstract] [Full Text] [PDF]

				G. Swaminath, J. Steenhuis, B. Kobilka, and T. W. Lee Allosteric Modulation of beta 2-Adrenergic Receptor by Zn2+ Mol. Pharmacol., January 1, 2002; 61(1): 65 - 72. [Abstract] [Full Text] [PDF]

				K. A. Neve, M. G. Cumbay, K. R. Thompson, R. Yang, D. C. Buck, V. J. Watts, C. J. DuRand, and M. M. Teeter Modeling and Mutational Analysis of a Putative Sodium-Binding Pocket on the Dopamine D2 Receptor Mol. Pharmacol., August 1, 2001; 60(2): 373 - 381. [Abstract] [Full Text] [PDF]

				J. A. Schetz and D. R. Sibley The Binding-Site Crevice of the D4 Dopamine Receptor Is Coupled to Three Distinct Sites of Allosteric Modulation J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 359 - 363. [Abstract] [Full Text]

				L. G. Hammerland, K. J. Krapcho, J. E. Garrett, N. Alasti, B. C. P. Hung, R. T. Simin, C. Levinthal, E. F. Nemeth, and F. H. Fuller Domains Determining Ligand Specificity for Ca2+ Receptors Mol. Pharmacol., April 1, 1999; 55(4): 642 - 648. [Abstract] [Full Text]

				D. G. Buerk, S. Osanai, A. Mokashi, and S. Lahiri Dopamine, sensory discharge, and stimulus interaction with CO2 and O2 in cat carotid body J Appl Physiol, November 1, 1998; 85(5): 1719 - 1726. [Abstract] [Full Text] [PDF]

				S. C. Sealfon, L. Chi, B. J. Ebersole, V. Rodic, D. Zhang, J. A. Ballesteros, and H. Weinstein Related Contribution of Specific Helix 2 and 7 Residues to Conformational Activation of the Serotonin 5-HT[IMAGE] Receptor J. Biol. Chem., July 14, 1995; 270(28): 16683 - 16688. [Abstract] [Full Text] [PDF]

				D. Armstrong and P. G. Strange Dopamine D2 Receptor Dimer Formation. EVIDENCE FROM LIGAND BINDING J. Biol. Chem., June 15, 2001; 276(25): 22621 - 22629. [Abstract] [Full Text] [PDF]